Skip to main content

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

BEAM holding history

Beam Therapeutics Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BEAM overviewAll 13F holders of BEAMFull Q2 2026 holdings

Shares (Q2 2026)
14,751
Value
$506.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BEAM by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,751$506.3K<0.1%+79+0.5%AddedHolders
Q1 202614,672$349.6K<0.1%+13,895+1,788.3%AddedHolders
Q4 2025777$21.5K<0.1%00.0%UnchangedHolders
Q3 2025777$18.9K<0.1%+185+31.3%AddedHolders
Q2 2025592$10.1K<0.1%−64−9.8%ReducedHolders
Q1 2025656$12.8K<0.1%+348+113.0%AddedHolders
Q4 2024308$7.64K<0.1%−276−47.3%ReducedHolders
Q3 2024584$14.3K<0.1%−1,651−73.9%ReducedHolders
Q2 20242,235$52.4K<0.1%−9−0.4%ReducedHolders
Q1 20242,244$74.1K<0.1%+227+11.3%AddedHolders
Q4 20232,017$54.9K<0.1%−7−0.3%ReducedHolders
Q3 20232,024$48.7K<0.1%+1,707+538.5%AddedHolders
Q2 2023317$10.1K<0.1%−294−48.1%ReducedHolders
Q1 2023611$18.7K<0.1%+189+44.8%AddedHolders
Q4 2022422$16.5K<0.1%−6,287−93.7%ReducedHolders
Q3 20226,709$319.0K<0.1%−539−7.4%ReducedHolders
Q2 20227,248$282.0K<0.1%−3,554−32.9%ReducedHolders
Q1 202210,802$619.0K<0.1%+571+5.6%AddedHolders
Q4 202110,231$815.0K<0.1%+600+6.2%AddedHolders
Q3 20219,631$839.0K<0.1%+153+1.6%AddedHolders
Q2 20219,478$1.22M<0.1%+4,441+88.2%AddedHolders
Q1 20215,037$403.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.